Biogen Idec, Inc. (Massachusetts) Increases Revenue 6 Percent to $1.4 Billion in the Third Quarter

October 25, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today announced third quarter 2012 financial results, delivering revenue growth of 6 percent to $1.4 billion and non-GAAP diluted Earnings Per Share (EPS) growth of 19 percent.

Twitter
LinkedIn
Facebook
Email
Print

Earnings

Biogen